超极化-MRI在多变性心肌病:一个叙述性审查
Ali Malik1, Sukruth Pradeep Kundur1, Sanjay Sivalokanathan2
1Faculty of Life Sciences and Medicine, King's College London, UK.
Clinical Medicine Insights. Cardiology
|September 2, 2025
概括
超极化磁共振成像 (HP-MRI) 通过可视化代谢变化来诊断多变性心肌病. 这项技术可以为HCM患者提前检测和个性化风险分层.
科学领域:
- 心血管成像
- 代谢成像
- 缩性心肌病研究
背景情况:
- 缩性心肌病 (HCM) 是一种遗传性心脏病,具有各种症状和风险,如心脏突然死亡.
- 目前的成像方法 (心声学,心脏MRI) 检测到结构问题,但错过了潜在的代谢问题.
- 了解细胞和代谢障碍是HCM进展和管理的关键.
研究的目的:
- 探索超极化磁共振成像 (HP-MRI) 在诊断和管理HCM方面的潜力.
- 评估HP-MRI在HCM中可视化代谢途径的能力.
- 评估HP-MRI用于早期诊断,风险分层和监测HCM的治疗反应.
主要方法:
- 使用超极化磁共振成像 (HP-MRI) 和像[1-13C]pyruvate这样的代谢物.
- 在心肌细胞中的代谢途径的非侵入性和非电离性可视化.
- 将HP-MRI发现与传统的心血管成像方法进行比较.
主要成果:
- 通过HP-MRI可可视化代谢途径,提供有关心肌细胞代谢的见解.
- 从其他心脏病中区分HCM的潜力 (例如,糖原储存障碍,心脏粉症).
- 在诊断和监测的临床前和小规模研究中证明有效.
结论:
- 惠普MRI具有早期HCM检测和个性化风险分层的巨大潜力.
- 它可以通过追踪代谢变化来监测治疗反应.
- 为了将HP-MRI整合到HCM的临床实践中,需要对更大群体进行进一步的研究.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:25Cardiomyopathy I: Introduction and Classification
50
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
27
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
27
01:21Imaging Studies for Cardiovascular System IV: CMRI
135
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
135
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21